RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells
Authors:
Open Access
- 14 May 2015
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 6 (5) , e1760
Abstract
Cancer-initiating cell (CIC) is critical in cancer development, maintenance and recurrence. The reverse expression pattern of coxsackie and adenovirus receptor (CAR) and αν integrin in bladder cancer decreases the infection efficiency of adenovirus. We constructed Arg-Gly-Asp (RGD)-modified oncolytic adenovirus, carrying EGFP or TNF-related apoptosis-inducing ligand (TRAIL) gene (OncoAd.RGD-hTERT-EGFP/TRAIL), and applied them to CAR-negative bladder cancer T24 cells and cancer-initiating T24 sphere cells. OncoAd.RGD-hTERT-EGFP had enhanced infection ability and cytotoxic effect on T24 cells and T24 sphere cells, but little cytoxicity on normal urothelial SV-HUC-1 cells compared with the unmodified virus OncoAd.hTERT-EGFP. Notably, OncoAd.RGD-hTERT-TRAIL induced apoptosis in T24 cells and T24 sphere cells. Furthermore, it completely inhibited xenograft initiation established by the oncolytic adenovirus-pretreated T24 sphere cells, and significantly suppressed tumor growth by intratumoral injection. These results provided a promising therapeutic strategy for CAR-negative bladder cancer through targeting CICs.Keywords
This publication has 46 references indexed in Scilit:
- Normal and neoplastic urothelial stem cells: getting to the root of the problemNature Reviews Urology, 2012
- TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell populationBritish Journal of Cancer, 2010
- Cancer stem cells in solid tumors: elusive or illusive?Cell Communication and Signaling, 2010
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid TumorsMolecular Therapy, 2010
- Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic AdenovirusClinical Cancer Research, 2008
- Bladder Cancer Initiating Cells (BCICs) Are Among EMA−CD44v6+Subset: Novel Methods for Isolating Undetermined Cancer Stem (Initiating) CellsCancer Investigation, 2008
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectorsCancer Gene Therapy, 2005
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997